|
IMMX Immix Biopharma Inc 1873835 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-11,557,002.00 |
| Balance Sheet |
|
Current Assets
|
$233,790,071.00 |
|
Assets
|
$239,108,896.00 |
|
Current Liabilities
|
$9,301,705.00 |
|
Liabilities
|
$10,192,343.00 |
|
Equity
|
$228,916,553.00 |
|
Shares Out
|
71535679.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-21,562,698.00 |
|
Investing Cash Flow
|
$-2,131,172.00 |
| Market Analysis |
Market Cap
|
$941,409,535.64 |
|
Price
|
$13.16 |
|
BVPS
|
3.20 |
|
PB
|
4.11 |
|
EPS
|
-0.18 |
|
FCF
|
$-21,616,227.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:28 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMMX documents filed with the SEC.
IMMX Filings
Clear
